Parallax Volatility Advisers
CASC

Parallax Volatility Advisers’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Parallax Volatility Advisers’s Portfolio CASC Stock Details CASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,208
Closed -$19K – 5290
2017
Q4 		$19K Buy
+5,208
New +$21.3K ﹤0.01% 3690

Parallax Volatility Advisers's CASC Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 5,208 shares — an estimated $19K sold.

Parallax Volatility Advisers first reported a position in CASC in Q4 2017 and held it in 1 quarter. The position peaked at $19K in Q4 2017. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,208 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $19K.
  • Parallax Volatility Advisers first reported a position in Cascadian Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Cascadian Therapeutics, Inc. position peaked at $19K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.